A Post-market Registry of the MARIS-stent (Invatec) Implanted in the Superficial Femoral Artery

NCT01067885 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1051

Last updated 2012-04-12

No results posted yet for this study

Summary

The MARIS Register is a prospective, multicenter registry of implantation in the superficial femoral artery (SFA) with a CE marked stent (Maris / Invatec) intended to capture initial angiographic success, complication rate and symptomatic related revascularization by following the clinical process and duplex examinations at 6 and 12 month.

Conditions

Interventions

DEVICE

MARIS-stent (Invatec)

stenting of SFA with Maris nitinol stent/s

Sponsors & Collaborators

  • Medtronic Vascular

    collaborator INDUSTRY
  • Medical Care Center Prof. Mathey, Prof. Schofer, Ltd.

    lead OTHER

Principal Investigators

  • Hans Krankenbeg, MD · MCC Prof. Mathey, Prof. Schofer

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2009-12-31
Completion
2009-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01067885 on ClinicalTrials.gov